Humanigen Inc (HGENQ)

[JPG77]

I think what you're missing is there are other mab(s) out there that have shown to be superior to Lenzilumab, like CYDY's Leronlimab. Look at the results of their basket trial and P2 NASH results for example. That will make it an up-hill battle for Lenzilumab as it tries to survive a crushing blow this week. I'm not suggesting anyone sell their HGEN and buy CYDY, because as investors that's your decision, but at least you need to be aware of your options and try to keep the emotions out of your investment strategy.

But with Lenzilumab neutralizing a Cytokine Storm, now those cancer treatments are possible if taken with Lenzilumab.